S R Group

Host: Goat
Product: IgG, whole molecule
Conjugate: DyLight™ 405
Product Category: ChromPure® Purified Proteins from Normal Serums
RRID: AB_2337007

Host: Mouse
Product: IgG, whole molecule
Conjugate: Alexa Fluor® 594
Product Category: ChromPure® Purified Proteins from Normal Serums
RRID: AB_2337227

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-Monocyte antibody (AMA), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-Monocyte antibody (AMA) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-Monocyte antibody (AMA) and HRP-conjugated anti-Monocyte antibody (AMA) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-Monocyte antibody (AMA) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-myelin antibody IgA (AMA IgA), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-myelin antibody IgA (AMA IgA) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-myelin antibody IgA (AMA IgA) and HRP-conjugated anti-myelin antibody IgA (AMA IgA) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-myelin antibody IgA (AMA IgA) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-neutrophil antibody (ANA), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-neutrophil antibody (ANA) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-neutrophil antibody (ANA) and HRP-conjugated anti-neutrophil antibody (ANA) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-neutrophil antibody (ANA) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to Anti-Paragonimus antibody (IgG), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Anti-Paragonimus antibody (IgG) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain Anti-Paragonimus antibody (IgG) and HRP-conjugated Anti-Paragonimus antibody (IgG) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of Anti-Paragonimus antibody (IgG) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-Sa-antibody, make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-Sa-antibody is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-Sa-antibody and HRP-conjugated anti-Sa-antibody antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-Sa-antibody is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-rubella virus IgG antibody (anti-RV IgG), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-rubella virus IgG antibody (anti-RV IgG) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-rubella virus IgG antibody (anti-RV IgG) and HRP-conjugated anti-rubella virus IgG antibody (anti-RV IgG) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-rubella virus IgG antibody (anti-RV IgG) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-Sa-antibody, make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-Sa-antibody is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-Sa-antibody and HRP-conjugated anti-Sa-antibody antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-Sa-antibody is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to Anti-Saccharomyces cerevisiae antibody (ASCA), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Anti-Saccharomyces cerevisiae antibody (ASCA) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain Anti-Saccharomyces cerevisiae antibody (ASCA) and HRP-conjugated Anti-Saccharomyces cerevisiae antibody (ASCA) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of Anti-Saccharomyces cerevisiae antibody (ASCA) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to Anti-smooth muscle antibody (ASMA), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Anti-smooth muscle antibody (ASMA) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain Anti-smooth muscle antibody (ASMA) and HRP-conjugated Anti-smooth muscle antibody (ASMA) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of Anti-smooth muscle antibody (ASMA) is determined by comparing with the CUTOFF value.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to anti-succinate dehydrogenase complex subunit A flavoprotein antibody (IgG), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-succinate dehydrogenase complex subunit A flavoprotein antibody (IgG) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain anti-succinate dehydrogenase complex subunit A flavoprotein antibody (IgG) and HRP-conjugated anti-succinate dehydrogenase complex subunit A flavoprotein antibody (IgG) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of anti-succinate dehydrogenase complex subunit A flavoprotein antibody (IgG) is determined by comparing with the CUTOFF value.

This assay uses the quantitative enzyme immunoassay method. The provided microtiter plate in the kit is pre-coated with Anti-Sulfatide (Anti-Sulfatide IgM antibody). Standards or samples are added to the appropriate wells of the microtiter plate, along with a biotin-conjugated antibody specific to Anti-Sulfatide (Anti-Sulfatide IgM antibody) Then, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each well and incubated. Following this, TMB substrate solution is added. The enzyme-substrate reaction is stopped by adding a sulfuric acid solution, and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Anti-Sulfatide (Anti-Sulfatide IgM antibody) in the samples is determined by comparing the optical density (OD) of the samples to the standard curve.

This ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to anti-thrombopoietin receptor (C-MPL) autoantibody IgG. Standards or samples are added to the appropriate Micro-elisa strip plate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for anti-thrombopoietin receptor (C-MPL) autoantibody IgG is added to each Micro-elisa strip plate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain anti-thrombopoietin receptor (C-MPL) autoantibody IgG and HRP conjugated anti-thrombopoietin receptor (C-MPL) autoantibody IgG antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of anti-thrombopoietin receptor (C-MPL) autoantibody IgG. You can calculate the concentration of anti-thrombopoietin receptor (C-MPL) autoantibody IgG in the samples by comparing the OD of the samples to the standard curve.

This assay uses the quantitative enzyme immunoassay method. The provided microtiter plate in the kit is pre-coated with BSEP (Bile salt export pump). Standards or samples are added to the appropriate wells of the microtiter plate, along with a biotin-conjugated antibody specific to BSEP (Bile salt export pump). Then, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each well and incubated. Following this, TMB substrate solution is added. Only the wells that contain BSEP (Bile salt export pump), biotin-conjugated antibody, and enzyme-conjugated Avidin will show a color change. The enzyme-substrate reaction is stopped by adding a sulfuric acid solution, and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of BSEP (Bile salt export pump) in the samples is determined by comparing the optical density (OD) of the samples to the standard curve.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to Bullous Pemphigoid (BP) antibody (IgG), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Bullous Pemphigoid (BP) antibody (IgG) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain Bullous Pemphigoid (BP) antibody (IgG) and HRP-conjugated Bullous Pemphigoid (BP) antibody (IgG) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of Bullous Pemphigoid (BP) antibody (IgG) is determined by comparing with the CUTOFF value.

This ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to Calcitonin (CT). Standards or samples are added to the appropriate Micro-elisa strip plate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Calcitonin (CT) is added to each Micro-elisa strip plate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain Calcitonin (CT) and HRP conjugated Calcitonin (CT) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of Calcitonin (CT). You can calculate the concentration of Calcitonin (CT) in the samples by comparing the OD of the samples to the standard curve.

This ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to Carboxypeptidase A4 (CPA4). Standards or samples are added to the appropriate Micro-elisa strip plate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Carboxypeptidase A4 (CPA4) is added to each Micro-elisa strip plate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain Carboxypeptidase A4 (CPA4) and HRP conjugated Carboxypeptidase A4 (CPA4) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of Carboxypeptidase A4 (CPA4). You can calculate the concentration of Carboxypeptidase A4 (CPA4) in the samples by comparing the OD of the samples to the standard curve.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to Chlamydia IgG, make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Chlamydia IgG is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain Chlamydia IgG and HRP-conjugated Chlamydia IgG antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of Chlamydia IgG is determined by comparing with the CUTOFF value.

Host: Mouse
Product: IgG, whole molecule
Conjugate: DyLight™ 405
Product Category: ChromPure® Purified Proteins from Normal Serums
RRID: AB_2337219

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to borrelia burgdorferi (Bb) antibody (IgG), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for borrelia burgdorferi (Bb) antibody (IgG) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain borrelia burgdorferi (Bb) antibody (IgG) and HRP-conjugated borrelia burgdorferi (Bb) antibody (IgG) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of borrelia burgdorferi (Bb) antibody (IgG) is determined by comparing with the CUTOFF value.

This ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to Calprotectin (CALP). Standards or samples are added to the appropriate Micro-elisa strip plate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for Calprotectin (CALP) is added to each Micro-elisa strip plate well and incubated. Free components are washed away. The TMB substrate solution is added to each well. Only those wells that contain Calprotectin (CALP) and HRP conjugated Calprotectin (CALP) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to the concentration of Calprotectin (CALP). You can calculate the concentration of Calprotectin (CALP) in the samples by comparing the OD of the samples to the standard curve.

The ELISA is based on the the qualitative immunoassay technique. The Microplate provided in this kit has been pre-coated with an Antibody specific to chikungunya virus IgG (CHIKV-IgG), make it to solid-phase antibody. Samples are added to the Microplate wells and combined to the specific antibody. Then a Horseradish Peroxidase (HRP)-conjugated antibody specific for chikungunya virus IgG (CHIKV-IgG) is added to each Microplate well and incubated, so the antibody-antigen-Enzyme labeled antibody complex is formed. Following a wash to remove any unbound reagent, then the TMB substrate solution is added to each well. Only those wells that contain chikungunya virus IgG (CHIKV-IgG) and HRP-conjugated chikungunya virus IgG (CHIKV-IgG) antibody will appear blue in color and then turn yellow after the addition of the stop solution. The optical density (OD) is measured spectrophotometrically at a wave length of 450 nm. The qualitative determination of chikungunya virus IgG (CHIKV-IgG) is determined by comparing with the CUTOFF value.

Addition Information :
Mouse Monoclonal Antibodies are highly specialized proteins designed for precise targeting and binding to specific antigens, making them invaluable tools in research, diagnostics, and therapeutic applications. These antibodies are produced through a sophisticated hybridoma technology, ensuring a consistent and high-quality product that exhibits exceptional specificity and affinity for their respective targets. With their ability to recognize and bind to unique epitopes, Mouse Monoclonal Antibodies facilitate accurate detection and quantification of proteins, enabling researchers to gain deeper insights into cellular processes and disease mechanisms. Ideal for use in various applications such as Western blotting, immunohistochemistry, and flow cytometry, these antibodies are essential for advancing scientific discovery and improving clinical outcomes. Invest in Mouse Monoclonal Antibodies to enhance the reliability and reproducibility of your experiments, ensuring that you achieve the best possible results in your research endeavors.

Mouse CD34 Monoclonal Antibody is a specialized laboratory tool used to detect the CD34 protein, a - transmembrane sialomucin marker for hematopoietic stem cells, progenitors, and vascular endothelial cells. Primarily used in flow cytometry and immunohistochemistry, this antibody helps identify stem cells, study cell adhesion, and detect vascular tumors. 

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.

Monoclonal antibodies (mAbs) are treatments that target specific proteins and help your immune system fight disease. They can also reduce inflammation caused by your immune system. Healthcare providers use monoclonal antibodies to treat autoimmune diseases, cancer, neurological diseases, osteoporosis, infectious diseases and more.